Evidence map›Paper›PMID 28729319›Full record

Trial reportBMJ open2017

Accelerated enhanced

Brandee A Price, Brian K Bednarski, Y Nancy You, Meryna Manandhar, E Michelle Dean, Zeinab M Alawadi, B Bryce Speer, Vijaya Gottumukkala, Marla Weldon, Robert L Massey and 3 more

Registry-linked trialAbstract readRandomized Controlled Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in BMJ open, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02613728 (Accelerated Enhanced RECOVERy Following Minimally Invasive Colorectal Cancer Surgery), which is not on this map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02613728 nacompletednot on this map

Accelerated Enhanced RECOVERy Following Minimally Invasive Colorectal Cancer Surgery (RecoverMI)

TypeinterventionalSponsorM.D. Anderson Cancer CenterRan2016 to 2022Enrolled32ConditionsColorectal CancerArmsAccelerated Recovery Plan, Early Discharge, Telemedicine, Standard Enhanced Care
3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Brandee A PriceDepartment of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Brian K BednarskiDepartment of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Y Nancy YouDepartment of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Meryna ManandharDepartment of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
E Michelle DeanDepartment of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Zeinab M AlawadiUTHealth Center for Clinical and Translational Sciences, Houston, Texas, USA.
B Bryce SpeerDepartment of Anesthesiology and Perioperative Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Vijaya GottumukkalaDepartment of Anesthesiology and Perioperative Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Marla WeldonDepartment of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Robert L MasseyDepartment of Nursing, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Xuemei WangDepartment of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Wei QiaoDepartment of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
George J ChangDepartment of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Fabien Delerue · 1985 to 2026
$290.8M
NCI NIH HHS P30 CA016672
6 · The paper itself

Abstract

introductionDefinitive treatment of localised colorectal cancer involves surgical resection of the primary tumour. Short-stay colectomies (eg, 23-hours) would have important implications for optimising the efficiency of inpatient care with reduced resource utilisation while improving the overall recovery experience with earlier return to normalcy. It could permit surgical treatment of colorectal cancer in a wider variety of settings, including hospital-based ambulatory surgery environments. While a few studies have shown that discharge within the first 24 hours after minimally invasive colectomy is possible, the safety, feasibility and patient acceptability of a protocol for short-stay colectomy for colorectal cancer have not previously been evaluated in a prospective randomised study. Moreover, given the potential for some patients to experience a delay in recovery of bowel function after colectomy, close outpatient monitoring may be necessary to ensure safe implementation. METHODS AND ANALYSIS: In order to address this gap, we propose a prospective randomised trial of accelerated enhanced TRIAL REGISTRATION NUMBER: NCT02613728; Pre-results.

Indexed as

ColectomyMinimally Invasive Surgical ProceduresAdolescentAdultAgedAmbulatory Surgical ProceduresColorectal NeoplasmsCommunicationDouble-Blind MethodFemaleHumansLength of StayMaleMiddle AgedPatient DischargePostoperative Carecolorectal cancercolorectal surgeryenhanced recovery after surgerytelemedicine

Identifiers

PMID28729319
PMCPMC5642654

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.